Hugo Larose

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

Health research policy and systems

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Hugo Larose, Myrto Lee, Jens Grueger, Amélie Anota, Nicolas Naïditch, Bruno Falissard, Mario Di Palma, Olivier Chassany, Laura Khalfallah-Neelz, Sarah Palazuelos-Muñoz, Aymeric Tetafort
Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process. Health research policy and systems 21 (1) (2023)
Hugo Larose, Myrto Lee, Jens Grueger, Amélie Anota, Nicolas Naïditch, Bruno Falissard, Mario Di Palma, Olivier Chassany, Laura Khalfallah-Neelz, Sarah Palazuelos-Muñoz, Aymeric Tetafort
Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process. Health research policy and systems 21 (1) (2023)
Hugo Larose, Myrto Lee, Jens Grueger, Amélie Anota, Nicolas Naïditch, Bruno Falissard, Mario Di Palma, Olivier Chassany, Laura Khalfallah-Neelz, Sarah Palazuelos-Muñoz, Aymeric Tetafort
Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process. Health research policy and systems 21 (1) (2023)
Cosimo Lobello, Boris Tichy, Vojtech Bystry, Lenka Radova, Daniel Filip, Marek Mraz, Ivonne-Aidee Montes-Mojarro, Nina Prokoph, Hugo Larose, Huan-Chang Liang, Geeta G Sharma, Luca Mologni, David Belada, Katerina Kamaradova, Falko Fend, Carlo B Gambacorti-Passerini, Olaf Merkel, Suzanne D Turner, Andrea Janikova, Sarka Pospisilova
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia 35 (5) (2020)

Hugo Larose.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hugo Larose